HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

May Khanna Selected Research

Semaphorin-3A

12/2019Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief.
10/2018Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
12/2017CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.
1/2016Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
7/2012CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
3/2012A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.
6/2011Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


May Khanna Research Topics

Disease

14Pain (Aches)
11/2021 - 06/2011
10Neoplasms (Cancer)
12/2020 - 08/2010
8Chronic Pain
12/2019 - 09/2011
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2019
7Neuralgia (Stump Neuralgia)
12/2019 - 03/2012
6Hyperalgesia
12/2019 - 01/2016
6Hypersensitivity (Allergy)
01/2018 - 06/2011
5Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 03/2012
5Neoplasm Metastasis (Metastasis)
11/2014 - 10/2011
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 01/2019
2Postoperative Pain
01/2018 - 07/2015
2Acquired Immunodeficiency Syndrome (AIDS)
07/2012 - 03/2012
2Migraine Disorders (Migraine)
03/2012 - 09/2011
2Lung Neoplasms (Lung Cancer)
04/2011 - 08/2010
1Parkinson Disease (Parkinson's Disease)
01/2022
1Severe Acute Respiratory Syndrome
10/2021
1COVID-19
10/2021
1limbic-predominant age-related TDP-43 encephalopathy
08/2021
1Proteostasis Deficiencies
08/2021
1Alzheimer Disease (Alzheimer's Disease)
12/2019
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2019
1Neuroblastoma
09/2018
1Neurofibromatoses (Neurofibromatosis)
12/2017
1Surgical Wound
07/2015
1Lafora Disease
12/2013
1Headache (Headaches)
03/2012
1Breast Neoplasms (Breast Cancer)
10/2011
1Demyelinating Diseases (Demyelinating Disease)
09/2011
1Carcinoma (Carcinomatosis)
04/2011
1Lymphoma (Lymphomas)
08/2010

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
08/2021 - 08/2010
8Peptides (Polypeptides)IBA
01/2018 - 06/2011
7Semaphorin-3AIBA
12/2019 - 06/2011
6Pharmaceutical PreparationsIBA
01/2022 - 08/2010
6Calcium Channels (Calcium Channel)IBA
01/2016 - 06/2011
4CalciumIBA
12/2019 - 01/2018
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022 - 01/2019
3Ion Channels (Ion Channel)IBA
12/2019 - 12/2017
3Voltage-Gated Sodium ChannelsIBA
10/2018 - 12/2016
3Amino AcidsFDA Link
01/2018 - 09/2011
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2012 - 10/2011
2SodiumIBA
11/2021 - 12/2019
2Sodium Channels (Sodium Channel)IBA
12/2019 - 01/2019
2Biological ProductsIBA
01/2019 - 03/2012
2LigandsIBA
10/2018 - 08/2010
2LacosamideFDA Link
12/2017 - 01/2016
2Urokinase Plasminogen Activator ReceptorsIBA
08/2012 - 11/2011
2Capsaicin (Zostrix)FDA Link
03/2012 - 06/2011
2IsoenzymesIBA
12/2011 - 05/2011
1Protein AggregatesIBA
01/2022
1diazonaphthalenedisulfonic acid (NDS)IBA
01/2022
1Antihypertensive Agents (Antihypertensives)IBA
10/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2021
1Angiotensin Receptor AntagonistsIBA
10/2021
1Losartan (Cozaar)FDA LinkGeneric
10/2021
1Lisinopril (Prinivil)FDA LinkGeneric
10/2021
1Angiotensin-Converting Enzyme 2IBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
08/2021
1Apoptosis Regulatory ProteinsIBA
12/2020
1Methylcellulose (BFL)IBA
12/2020
1naringeninIBA
12/2019
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
12/2019
1maleic acid (maleate)IBA
12/2019
1Opioid Analgesics (Opioids)IBA
01/2019
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1QuinazolinesIBA
01/2019
1UbiquitinIBA
10/2018
1TATA-Box Binding Protein (TATA-Binding Protein)IBA
09/2018
1EnzymesIBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1Neurofibromin 1 (Neurofibromin)IBA
12/2017
1Dopamine (Intropin)FDA LinkGeneric
01/2016
1CarrageenanIBA
07/2015
1GTP Phosphohydrolases (GTPases)IBA
11/2014
1GlycogenIBA
12/2013
1Serine Proteases (Serine Protease)IBA
08/2012
1Phenylalanine (L-Phenylalanine)FDA Link
03/2012
1CBD3 peptideIBA
03/2012
1Stavudine (Zerit)FDA LinkGeneric
03/2012
1Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2012
12- ((3- (3,5- dimethylpiperidin- 1- yl)- 6- oxo- 6H- anthra(1,9- cd)isoxazol- 5- yl)amino)benzoic acidIBA
11/2011
1NeuropeptidesIBA
06/2011
1tat Gene Products (tat Protein)IBA
06/2011
1Trans-Activators (Trans-Acting Factor)IBA
06/2011
1Formaldehyde (Formol)FDA Link
06/2011
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
04/2011
1Phosphotransferases (Kinase)IBA
04/2011
1Protein Glutamine gamma Glutamyltransferase 2IBA
04/2011
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2010
1MenogarilIBA
08/2010

Therapy/Procedure

10Therapeutics
01/2022 - 03/2012
3Drug Therapy (Chemotherapy)
01/2019 - 01/2019
2Ligation
01/2019 - 01/2019
1Subcutaneous Infusions
01/2016
1Lasers (Laser)
03/2012